Pharmaceutical Sciences conference| Upcoming Pharmaceutical Sciences Conferences |pharma conference |pharmaceutical science meet| pharma meets 2022

Theme: Latest Trends in Pharmacy : Spanning the Gap in Research and Product Commercialization

PHARMA MEET 2021

Renowned Speakers

Dina Bahaa El Din Mahmoud
Cairo University Egypt
Egypt

Hanan Fael
KoÃ§ University, Turkey
Turkey

Hyungil Jung
Yonsei University South South Korea
South Korea

PHARMA MEET 2021

Following the tradition of successful Congresses held in several European countries, Dubai, Spain, Italy, India, South Africa and USA, the Organizing Committee of Conference Series Ltd is pleased to invite all the participants across the globe to attend the 20th Annual Meet on Pharmaceutical Sciences slated on May 10-11, 2021 , Webinar.

The conference is a specially organized two-day event which will provide a multi-channel communication platform that brings together both “producers” and “consumers” of pharma world of generic sector. It includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. It is a perfect platform for researchers, scientists and, delegates to share experience, foster collaborations across industry and academia, and evaluate emerging technologies across the globe.

Motives to attend:

Keynote presentation along with interactions to galvanize the scientific community.

Workshop and symposiums to reach the largest assemblage of participants from the Pharma community.

A wide track of exhibitors to showcase the new and emerging technologies.

Platform to global investment community to connect with stakeholders in Pharma sector.

Young Scientist/ Investigators Award geared towards best budding young research.

Links to the political marketing resources to expand your business and research network.

Triumph of Awards, Certificates recognizes your commitment to your profession to encourage the nascent research.

Target Audience:

Researchers

Directors, CEO’s of Organizations

Scholars from Pharmaceutical backgrounds

PhD Scholars

Drug Delivery Technology Manufacturers

Business Development Managers

Distributors and Suppliers of Drug Delivery Technologies

Students, Professors, Researchers, and Faculty of Pharmaceutical Sciences from Universities and Medical Colleges

Researchers from Pharmaceutical Companies, Pharmacy Associations and Societies

Health professionals

Pharmacists

Business development professionals, Consultants and Pharma service providers

Quality control specialist

Graduates and postgraduates in industrial pharmacy

Medical Devices Manufacturing Companies, CRO

Data Management Companies.

Pharmaceutical legislators and regulators

Track 1: Globalized Pharma Sector

Globalized Pharma Sector is based on gaining information on changing structure of competition and increased competitiveness, lack of brand new products, despite increased investments into R&D Research and Development activities, increased importance of regulatory issues (registrations, intellectual property rights, litigations), fast consolidation and concentration of the world Pharmaceutical industry can be known as the Globalized Pharma Sector.

14^th Nano medicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 10^th Pharmacology Conferences, Jul 30-Aug 01, 2018 at Barcelona, Spain; 4^th Marine Drugs and Natural Products Conferences June 11-13, 2018 at Rome, Italy; 8th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 9^th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4^th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13^th European Pharma Conferences May 07-09, 2018 at Frankfurt, Germany.

Bio pharmaceutics Technology Meeting, March 19-22, 2018, Granada, Spain; Pharma dedicated packaging & drug delivery event February 07-08, 2018, Paris, France; Conference on Supply Chain Security and Management October 24-26, 2018 Berlin, Germany; World Congress of Pharmacy September 02-06, 2018, Glasgow, UK.

Related Societies:

Societies in USA: Canadian Society for Pharmaceutical Sciences (CSPS), Pharmaceutical Manufacturers Association of Canada (PMAC), American Association of Pharmacy Technicians (AAPT), American Society of Health-System Pharmacists (ASHYP).

Societies in Europe: Belgian Society of Pharmaceutical Sciences (BGFW), European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF), Association of the British Pharmaceutical Industry (ABPI).

Societies in Asia and Pacific: The Pharmaceutical Society of Australia (PSA) , Austrian Pharmaceutical Society (APS), Korean Research-based Pharmaceutical Industry Association (KRPIA), Kuwait Pharmaceutical Association (KPA).

Track 2: Drug Discovery

In the fields of medicine, biotechnology and Pharmacology, drug discovery is the process by which new candidate medications are discovered. Modern drug discovery involves the identification of screening hits, medicinal chemistry and optimization of those hits to increase the affinity, selectivity (to reduce the potential of side effects), efficacy or potency, metabolic stability (to increase the half-life), and oral bioavailability.

8^th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 9^th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4^th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13^th European Pharma Conferences May 07-09, 2018 at Frankfurt, Germany; 14^th Nano medicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 10^th Pharmacology Conferences, Jul 30-Aug 01, 2018 at Barcelona, Spain; 4^th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy.

Pharma dedicated packaging & drug delivery event February 07-08, 2018, Paris, France; Conference on Supply Chain Security and Management October 24-26, 2018 Berlin, Germany; World Congress of Pharmacy September 02-06, 2018, Glasgow, UK; Bio pharmaceutics Technology Meeting, March 19-22, 2018, Granada, Spain.

Related Societies:

Societies in USA: American Association of Pharmacy Technicians (AAPT), American Society of Health-System Pharmacists (ASHYP), Canadian Society for Pharmaceutical Sciences (CSPS), Pharmaceutical Manufacturers Association of Canada (PMAC).

Societies in Europe: Italian Society for Pharmaceutical Sciences (SISF), Association of the British Pharmaceutical Industry (ABPI), Belgian Society of Pharmaceutical Sciences (BGFW), European Federation for Pharmaceutical Sciences (EUFEPS).

Societies in Asia and Pacific: Korean Research-based Pharmaceutical Industry Association (KRPIA), The Pharmaceutical Society of Australia (PSA), Austrian Pharmaceutical Society (APS), Kuwait Pharmaceutical Association (KPA).

Track 3: Drug Development

Drug development focusses on launch of new Pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery. It includes pre-clinical research on microorganisms and animals, filing for regulatory status, such as via the United States Food and Drug Administration for an investigational new drug to initiate clinical trials on humans, and may include the step of obtaining regulatory approval with a new drug application to market the drug.

14^th Nanomedicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 10^th Pharmacology Conferences, Jul 30-Aug 01, 2018 at Barcelona, Spain; 4^th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 8^th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 9^th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4^th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13^th European Pharma Conferences May 07-09, 2018 at Frankfurt, Germany.

Related Societies:

Track 4: Pharmaceutical Sciences

The pharmaceutical sciences combine broad range of scientific disciplines that are critical to the discovery and development of new drugs and therapies. Pharmaceutical Sciences is a dynamic and interdisciplinary field that aims to integrate fundamental principles of physical and organic chemistry, engineering, biochemistry, and biology to understand how to optimize delivery of drugs to the body and translate this integrated understanding into new and improved therapies against human disease. At the many of institutes internationally recognized faculty contribute to the field through inquiry into the underlying mechanisms of drug interactions with the human body and development of advanced synthetic or biologically derived materials that can modulate these interactions in pursuit of better and safer therapies and drug products.

8^th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 9^th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4^th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13^th European Pharma Conferences May 07-09, 2018 at Frankfurt, Germany; 14^th Nanomedicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 10^th Pharmacology Conferences, Jul 30-Aug 01, 2018 at Barcelona, Spain; 4^th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy.

Related Societies:

Track 5: Drug Targeting and Design

The most fundamental goal in drug design is to predict whether a given molecule will bind to a target and if so, how strongly. Molecular mechanics or molecular dynamics are most often used to predict the conformation of the small molecule and to model conformational changes in the biological target that may occur when the small molecule binds to it. The therapeutic response of a drug depends upon the interaction of drug molecules with cell-on-cell membrane related biological events at receptor sites in concentration dependent manner.

Selective and effective localization of the pharmacologically active moiety at pre identified target(s) in therapeutic concentration, while restricting its access to non-target(s) normal cellular linings, thus minimizing toxic effects, and maximizing the therapeutic index accounts from effective and efficient drug delivery.

Molecular mechanics methods may also be used to provide semi-quantitative prediction of the binding affinity. Also, knowledge-based scoring function may be used to provide binding affinity estimates. These methods use linear regression, machine learning, neural nets, or other statistical techniques to derive predictive binding affinity equations by fitting experimental affinities to computationally derived interaction energies between the small molecule and the target.

Ideally, the computational method will be able to predict affinity before a compound is synthesized and hence in theory only one compound needs to be synthesized, saving enormous time and cost. The reality is that present computational methods are imperfect and provide, at best, only qualitatively accurate estimates of affinity. In practice it still takes several iterations of design, synthesis, and testing before an optimal drug is discovered. Computational methods have accelerated discovery by reducing the number of iterations required and have often provided novel structures.

8^th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 9^th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4^th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13^th European Pharma Conferences May 07-09, 2018 at Frankfurt, Germany; 14^th Nanomedicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 10^th Pharmacology Conferences, Jul 30-Aug 01, 2018 at Barcelona, Spain; 4^th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy.

Related Societies:

Track 6: Pharmaceutical Nanotechnology

Pharmaceutical Nanotechnology deals with emerging new technologies for developing customized solutions for drug delivery systems. The drug delivery system positively impacts the rate of absorption, distribution, metabolism, and excretion of the drug or other related chemical substances in the body. In addition to this the drug delivery system also allows the drug to bind to its target receptor and influence that receptor’s signalling and activity. Pharmaceutical nanotechnology embraces applications of Nano science to pharmacy as nanomaterial and as devices like drug delivery, diagnostic, imaging and biosensor.

Related Conferences: Pharma Conferences | Pharmaceutical Meetings | Pharma Science Events | Pharmaceutical Symposium | Pharma Workshops

14^th Nanomedicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 10^th Pharmacology Conferences, Jul 30-Aug 01, 2018 at Barcelona, Spain; 4^th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 8^th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 9^th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4^th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13^th European Pharma Conferences May 07-09, 2018 at Frankfurt, Germany.

Related Societies:

Track 7: Drug Delivery Technologies

A route of administration is the path by which a drug, fluid, poison, or other substance is taken into the body. Routes of administration are generally classified by the location at which the substance is applied. Common examples include oral and intravenous administration. Routes can also be classified based on where the target of action is. Action may be topical (local), enteral (system-wide effect, but delivered through the gastrointestinal tract), or parenteral (systemic action, but delivered by routes other than the GI tract).

Routes of administration are usually classified by application location (or exposition). The route or course the active substance takes from application location to the location where it has its target effect is usually rather a matter of pharmacokinetics (concerning the processes of uptake, distribution, and elimination of drugs). Nevertheless, some routes, especially the transdermal or trans mucosal routes are commonly referred to routes of administration. The location of the target effect of active substances is usually rather a matter of pharmacodynamics (concerning e.g., the physiological effects of drugs). Furthermore, there is also a classification of routes of administration that basically distinguishes whether the effect is local (in "topical" administration) or systemic (in "enteral" or "parenteral" administration).

8^th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 9^th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4^th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13^th European Pharma Conferences May 07-09, 2018 at Frankfurt, Germany; 14^th Nanomedicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 10^th Pharmacology Conferences, Jul 30-Aug 01, 2018 at Barcelona, Spain; 4^th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy.

Related Societies:

Track 8: Regulatory Requirements for Pharmaceuticals

The area unit variety of motives for extending the merchandise development outside of the mature, developed economies (e.g., the EU and therefore the US) and most of them have faith in the high population and market potential of rising markets. FDA guidance for clinical investigations and Pharmaceutical development goes a lot of and a lot of international within the direction of rising markets that tend to supply solutions for the patient achievement and overall development prices and timelines.

8^th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 9^th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4^th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13^th European Pharma Conferences May 07-09, 2018 at Frankfurt, Germany; 14^th Nanomedicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 10^th Pharmacology Conferences, Jul 30-Aug 01, 2018 at Barcelona, Spain; 4^th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy.

Related Societies:

Track 9: Smart Drug Delivery Systems

Smart drug delivery is a method of delivering medication to a patient in a manner that increases the concentration of the medication in some parts of the body relative to others. This means of delivery is largely founded on Nano medicine, which plans to employ nanoparticle-mediated drug delivery to combat the downfalls of conventional drug delivery. These nanoparticles would be loaded with drugs and targeted to specific parts of the body where there is solely diseased tissue, thereby avoiding interaction with healthy tissue. The goal of a targeted drug delivery system is to prolong, localize, target, and have a protected drug interaction with the diseased tissue. The conventional drug delivery system is the absorption of the drug across a biological membrane, whereas the targeted release system releases the drug in a dosage form. The advantages to the targeted release system are the reduction in the frequency of the dosages taken by the patient, having a more uniform effect of the drug, reduction of drug side-effects, and reduced fluctuation in circulating drug levels. The disadvantage of the system is high cost, which makes productivity more difficult and the reduced ability to adjust the dosages.

Targeted drug delivery systems have been developed to optimize regenerative techniques. The system is based on a method that delivers a certain amount of a therapeutic agent for a prolonged period to a targeted diseased area within the body. This helps maintain the required plasma and tissue drug levels in the body, thereby preventing any damage to the healthy tissue via the drug. The drug delivery system is highly integrated and requires various disciplines, such as chemists, biologists, and engineers, to join forces to optimize this system.

14^th Nanomedicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 10^th Pharmacology Conferences, Jul 30-Aug 01, 2018 at Barcelona, Spain; 4^th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 8^th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 9^th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4^th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13^th European Pharma Conferences May 07-09, 2018 at Frankfurt, Germany.

Related Societies:

Track 10: Purpose and Principles of GMP

Good Manufacturing Practices quality of drugs is essentially the responsibility of manufacturers. GMP Guidelines are means to assure this very quality of drugs. CGMP refers to the Current Good Manufacturing Practice regulations enforced by the US Food and Drug Administration (FDA). CGMPs provide for systems that assure proper design, monitoring, and control of manufacturing processes and facilities. Adherence to the CGMP regulations assures the identity, strength, quality, and purity of drug products by requiring that manufacturers of medications adequately control manufacturing operations. GMP is good common sense quality management quality assurance GMP production and quality control.

Related Conferences: Pharma Conferences | Pharmaceutical Meetings | Pharma Science Events | Pharmaceutical Symposium | Pharma Workshops

14^th Nanomedicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 10^th Pharmacology Conferences, Jul 30-Aug 01, 2018 at Barcelona, Spain; 4^th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 8^th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 9^th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4^th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13^th European Pharma Conferences May 07-09, 2018 at Frankfurt, Germany.

Related Societies:

Societies in USA Canadian Society for Pharmaceutical Sciences (CSPS), Pharmaceutical Manufacturers Association of Canada (PMAC), American Association of Pharmacy Technicians (AAPT), American Society of Health-System Pharmacists (ASHYP).

Track 11: Nanotechnology in Drug Delivery

Nanotechnology has finally and firmly entered the realm of drug delivery. Performances of intelligent drug delivery systems are continuously improved with the purpose to maximize therapeutic activity and to minimize undesirable side-effects. The primary goals for research of Nano-biotechnologies in drug delivery include:

More specific drug targeting and delivery,

Reduction in toxicity while maintaining therapeutic effects,

Greater safety and biocompatibility, and

Faster development of new safe medicines

Pharmaceutical conferences offer presentations by researchers from several disciplines, from the life sciences to engineering, who will address a range of topics including peptide and protein delivery, gene delivery, cell delivery, vaccines, transdermal, pulmonary delivery, new materials, and other subjects, from varied disciplines while focusing on the central theme of drug delivery.

Key players in the market include Amgen, Inc., AstraZeneca plc., Eli Lilly & Co., Ipsen S.A., Merck & Co., Novartis AG, Novo Nordisk A/S, Roche Holdings AG, Sanofi, Takeda Pharmaceutical Company Limited, and Teva Pharmaceutical Industries Limited. Leading API manufacturers include Bachem Holding AG, Polypeptide Group, Peptisyntha Inc. and Lonza Inc.

The global market for blood-brain barrier (BBB) technology for therapeutics reached $21.8 million in 2013. This market is expected to grow from $38.7 million in 2014 to $471.5 million in 2019, a compound annual growth rate (CAGR) of 64.9% from 2014 through 2019.

8^th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 9^th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4^th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13^th European Pharma Conferences May 07-09, 2018 at Frankfurt, Germany; 14^th Nanomedicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 10^th Pharmacology Conferences, Jul 30-Aug 01, 2018 at Barcelona, Spain; 4^th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy.

Related Societies:

Track 12: Generics versus Big Pharma

Yet over the past decade, most of the Big Pharma have adopted small molecule generics in one shape or form into their overall business model. And many of them openly talk about the “innovation headroom” that a healthy low-priced generics market enables i.e. the money saved on off-patent drugs can be used to fund high-priced new innovations. They have recognized that they cannot fight the realities of aging populations and healthcare economics.

Related Conferences: Pharma Conferences | Pharmaceutical Meetings | Pharma Science Events | Pharmaceutical Symposium | Pharma Workshops

Related Societies:

Track 13: Clinical Pharmacy and Therapeutics

Drug absorption is set by the Drug’s chemistry properties, Formulation, and route of administration. Dosage forms (e.g., tablets, capsules, solutions), consisting of the drug and alternative ingredients, square measure developed to lean by numerous routes (e.g., oral, buccal, sublingual, rectal, parenteral, topical, inhalational). Despite the route of administration, medicine should be in answer to be absorbed.

Related Conferences: Pharma Conferences | Pharmaceutical Meetings | Pharma Science Events | Pharmaceutical Symposium | Pharma Workshops

14^th Nanomedicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 10^th Pharmacology Conferences, Jul 30-Aug 01, 2018 at Barcelona, Spain; 4^th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 8^th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 9^th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4^th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13^th European Pharma Conferences May 07-09, 2018 at Frankfurt, Germany.

Related Societies:

Track 14: R&D Advancement: Road to New Medicines

Big pharmaceutical companies develop new business models to cope with the innovation crisis (patent loss, drying up of pipelines) and to improve their productivity in R&D and innovation. These pressures led big players to transform or reinvent their business models to sustain value creation from R&D and innovation. However, to our knowledge, there is still a lack of understanding regarding the “strategic alignment” of these organizational changes and on how they are perceived by organizational members.

8^th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 9^th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4^th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13^th European Pharma Conferences May 07-09, 2018 at Frankfurt, Germany; 14^th Nanomedicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 10^th Pharmacology Conferences, Jul 30-Aug 01, 2018 at Barcelona, Spain; 4^th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy.

Related Societies:

Track 15: Digital Pharma

Some of the people believes that digital capabilities are not only critical to Pharmaceutical companies’ ability to improve the way they roll out new products, but to increasing the Pharmaceutical industry’s contribution to health care by enabling it to provide innovative services to improve patients’ outcomes. To increase the perceived value of Pharma within the health care system, the industry is striving to respond to the needs of all stakeholders: health care professionals, patients, and payers. In the meantime, the culture of Pharmaceutical companies is shifting from one of separate departments working vertically to one that is cross functional.

14^th Nanomedicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 10^th Pharmacology Conferences, Jul 30-Aug 01, 2018 at Barcelona, Spain; 4^th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 8^th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 9^th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4^th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13^th European Pharma Conferences May 07-09, 2018 at Frankfurt, Germany.

Related Societies:

Track 16: Pharmaceutical Engineering

Drug Manufacturing is the process of industrial-scale synthesis of pharmaceutical drugs by pharmaceutical companies. The process of drug manufacturing can be broken down into a series of unit operations such as Milling, Granulation, Coating, Tablet pressing and others. Statistics are critical to the Pharmaceutical industry, from clinical operations through manufacturing. However, clinical and manufacturing statistics represent entirely different worlds. Where they might be well staffed on the clinical side, some Pharmaceutical companies today aren’t hiring qualified staff to analyze operations data, resulting in misapplied tools, inadequate CAPAs and superficial root cause analysis, all of which lead to financial loss and noncompliance.

8^th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 9^th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4^th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13^th European Pharma Conferences May 07-09, 2018 at Frankfurt, Germany; 14^th Nanomedicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 10^th Pharmacology Conferences, Jul 30-Aug 01, 2018 at Barcelona, Spain; 4^th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy.

Related Societies:

Track 17: Temper-Evident Pharmaceutical Packaging

Packaging plays an important role in providing protection, presentation, convenience, identification information, and compliance of a product during storage, transportation, display and until the product is safely consumed. Packaging may be considered as a system by which the product safely reaches from producer to consumer. The track mainly focuses on recent advances in packaging technology and packaging material. Many types of symbols for package labelling should be nationally and internationally standardized. Packaging symbols represent product certifications, trademarks, and proof of purchase.

14^th Nanomedicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 10^th Pharmacology Conferences, Jul 30-Aug 01, 2018 at Barcelona, Spain; 4^th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 8^th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 9^th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4^th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13^th European Pharma Conferences May 07-09, 2018 at Frankfurt, Germany.

Related Societies:

Track 18: Pharmaceutical Supply Chain Optimization

Quality cannot be adequately assured by in-process and finished inspections and testing but it should be built into the manufacturing process. These processes should be controlled in order that the finished product meets all quality specifications. Validation is one of the important steps in achieving and maintaining the quality of the final product. If each step of production process is validated, we can assure that the final product is of the best quality. Validation of the individual steps of the processes is called the process validation. Different dosage forms have different validation protocols. Process Validation is one of the important steps in achieving and maintaining the quality of final product. It gives a higher degree of assurance.

8^th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 9^th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4^th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13^th European Pharma Conferences May 07-09, 2018 at Frankfurt, Germany; 14^th Nanomedicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 10^th Pharmacology Conferences, Jul 30-Aug 01, 2018 at Barcelona, Spain; 4^th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy.

Related Societies:

Track 19: Pharmaceutical Process Validation

Pharmaceutical Process Validation is the most important and recognized parameters of CGMPs. Quality cannot be adequately assured by in-process and finished inspections and testing but it should be built into the manufacturing process. These processes should be controlled in order that the finished product meets all quality specifications. Validation is one of the important steps in achieving and maintaining the quality of the final product. The requirement of process validation appears of the quality system (QS) regulation. The goal of a quality system is to consistently produce products that are fit for their intended use.

14^th Nanomedicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 10^th Pharmacology Conferences, Jul 30-Aug 01, 2018 at Barcelona, Spain; 4^th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 8^th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 9^th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4^th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13^th European Pharma Conferences May 07-09, 2018 at Frankfurt, Germany.

Related Societies:

Track 20: Medico Marketing

Medico-Marketing focusses on exchange of drug information among drug manufacturing company and the recommending doctor, Nurse, Pharmacist or with the end user. The intention behind this data exchange is to describe the Pharmaceutical Company’s products and how it will benefit the patient community in diagnosis or management of the human ailments.

Related Conferences: Pharma Conferences | Pharmaceutical Meetings | Pharma Science Events | Pharmaceutical Symposium | Pharma Workshops

8^th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 9^th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4^th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13^th European Pharma Conferences May 07-09, 2018 at Frankfurt, Germany; 14^th Nanomedicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 10^th Pharmacology Conferences, Jul 30-Aug 01, 2018 at Barcelona, Spain; 4^th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy.

Related Societies:

Track 21: Pharma and Biotech Financial Outlook

The downturn in the global economy has forced Pharmaceutical and life sciences companies to focus on cost-saving initiatives, putting stress on finance departments. Although optimizing costs will always be important, reinvigorating R&D will most likely be a top strategic initiative for these companies as well. Most big Pharmaceutical companies are under competitive pressure from generic drug maker’s pressure that will become more intense as an increasing number of patents for “blockbuster” drugs expire during the next few years.

14^th Nanomedicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 10^th Pharmacology Conferences, Jul 30-Aug 01, 2018 at Barcelona, Spain; 4^th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 8^th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 9^th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4^th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13^th European Pharma Conferences May 07-09, 2018 at Frankfurt, Germany.

Related Societies:

Track 22: Entrepreneurs Investment Meet

A platform aimed to connect Entrepreneurs, Proposers, and the Investors worldwide. It is intended to create and facilitate the most optimized and viable meeting place for engaging people in global business discussions, evaluation, and execution of promising business ideas. An investor could be able to find out the highest potential investment opportunities globally.

Market Analysis

Past Conference Statistics:

The Organizing Committee of Conference Series Ltd invites all the participants across the globe to attend the 20th Annual Meet on Pharmaceutical Sciences on May 10-11,2021 Webinar.

Globalized growth of Pharmaceutical Research

Pharmaceuticals are one of the world's most beneficial ventures. In 2008 alone, the pharmaceutical business sold $773 billion in items around the world a number that has reliably developed for as long as 8 years and is anticipated to increment again by 2.5 to 3.5 per cent in 2017, as per the medication statistical surveying firm IMS Health.

In any case, the procedure that transforms look into dollars into pharmaceuticals is a moderate and regularly strenuous one. It now takes a normal of 12 to 15 years and up to $1.7 billion for a medication to go from revelation to advertise, as indicated by The Pharmaceutical Research and Manufacturers of America. Also, regardless of constantly and cash contributed, just a modest bunch of medications are affirmed by the FDA every year.

The laborious medication endorsement prepare uncovers a focal truth about Big Pharma: it's a standout amongst the most seriously controlled businesses on the planet. The U.S. Nourishment and Drug Administration (FDA) and its European Union partner, the European Medicines Agency (EMEA), represent each part of a medication's improvement from chemicals utilized as a part of the medication and clinical study directions, called conventions, to bundling segments and showcasing materials. This strict oversight is intended to ensure persistent wellbeing, and pharma organizations consider administrative oversight important. The consistent weight to hold fast to government commands shapes each part of a pharma company's association, operations, and culture. For instance, sedate organizations keep up capable administrative undertakings divisions-the offices that arrangement with government offices and they have a tendency to be hazard disinclined.The Pharmaceutical industry's long successful strategy of placing big bets on a few molecules, promoting them heavily and turning them into blockbusters worked well for many years, but its R&D productivity has now plummeted and the environment’s changing. There are few trends which are reshaping the marketplace.

Escalating demand for medicines

The global pharmaceutical market is growing steadily, with sales reaching $1.08 trillion in 2011 – a year-on-year increase of 7.8%. The mature economies proved very sluggish, but the growth economies were another matter. Sales in the BRIC countries (Brazil, China, India and Russia) rose by 22.6%, while sales in the other 13 growth countries (the ‘fast followers’, as we call them) rose by 7.2%.9 If this pattern continues, the market for medicines could be worth nearly $1.6 trillion by 2020. 10 Indeed, it could be worth even more. Demand for pharm a’s products is rising dramatically, as the global population increases, ages and becomes more sedentary. In 2010, there were an estimated 6.9 billion people. By 2020, there will be more than 7.6 billion.11 and, if present trends are any guide, many of them will have health problems In short, there are more people – and more sick or elderly people – in the world today than ever before. More people have access to affordable healthcare than ever before. And, by 2020, access to healthcare may well be regarded everywhere as a basic human right.

Poor scientific productivity

Take the vexed issue of the industry’s scientific productivity. Although the number of new medicines reaching the market picked up in 2011, pharm a’s annual output has effectively flat lined for the past 10 years. Developing new medicines is becoming an increasingly expensive business, too, although precisely how expensive is the subject of fierce debate. In 2006, the Tufts Centre for the Study of Drug Development put average costs per molecule at $1.24-1.32 billion.22 Various commentators have since challenged these figures, claiming that the real cost is anything from $75 million to $4 billion, although most people lean towards the higher end of the range.So where does the pharma industry now stand? It’s proved remarkably resilient, given the many problems it’s dealing with. But, in essence, it faces two overarching challenges. Tomorrow’s challenge is to develop new medicines that can prevent or cure currently incurable diseases. Today’s challenge is to get to tomorrow – and that’s a tall order in itself. Fortunately, there are a number of steps senior executives can take to help their companies reach 2020 and ready them for the opportunities the next decade brings.

Major Pharmaceutical Associations & Societies in Europe:

â–º Pharmaceutical Society of Ireland

â–º The International Society for Pharmaceutical Engineering (ISPE)

â–º The European Federation of Pharmaceutical Industries and Associations (EFPIA)

â–º The European Generic Medicines Association (EGA)

â–º The European Personalised Medicine Association EPEMED

â–º European Association of Employed Community Pharmacists in Europe (EPhEU)

â–º European Pharmaceutical Union (EPU)

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	May 10-11, 2021
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View

Useful Links

Special Issues

All accepted abstracts will be published in respective Our International Journals.

Abstracts will be provided with Digital Object Identifier by

20^th Annual Meet on Pharmaceutical Sciences May 10-11, 2021 Yokohama, Japan

Recommended Global Pharmaceutical Sciences Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Renowned Speakers

PHARMA MEET 2021

Conference Highlights

To Collaborate Scientific Professionals around the World

Useful Links

Special Issues